Ezetimibe Tablet
Product Images NDC 82804-211

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 82804-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-211-30 (Image 01)

82804-211-30 (Image 01)
Ezetimibe 10 mg tablets packaging label shows product quantity (#30 tablets), active ingredient strength, and physical description. The label includes the NDC 82804-211-30 and indicates the manufacturer as Glenmark Pharmaceuticals Limited, India. It is labeled for prescription use only, with storage instructions and safety warnings.*
FDA Label Image
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Ezetimibe, showing its molecular framework with fluorophenyl groups, hydroxyl groups, and a beta-lactam ring. The diagram includes stereochemistry indicated by wedge and dash bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.